CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Operating activities:
Net income attributable to common shareholders	$ 216,993	$ 26,315	$ 154,170
Noncontrolling interest in subsidiaries' earnings	828	201	20
Net income before allocation to noncontrolling interests	217,821	26,516	154,190
Asbestos Provision	0	241,647	0
Environmental charge	0	30,327	0
Gain on divestiture	(29,445)	(4,258)	(1,015)
Restructuring - Non Cash	3,855	0	0
Depreciation and amortization	57,263	62,943	59,841
Stock-based compensation expense	17,319	14,972	13,326
Defined benefit plans and postretirement expense	20,090	6,770	14,712
Deferred income taxes	55,000	(43,923)	31,453
Cash provided by (used for) operating working capital	1,824	(41,955)	(8,262)
Defined benefit plans and postretirement contributions	(5,504)	(48,113)	(43,226)
Environmental payments, net of reimbursements	13,371	9,534	11,063
Payments for asbestos-related fees and costs, net of insurance recoveries	(77,957)	(79,277)	(66,731)
Other	12,139	6,303	9,689
Total provided by operating activities	234,756	149,812	133,536
Investing activities:
Capital expenditures	(29,308)	(34,737)	(21,033)
Proceeds from disposition of capital assets	6,438	4,793	375
Proceeds from divestitures	54,079	1,000	4,615
Payment for acquisition, net of cash acquired	0	(36,590)	(140,461)
Total provided by (used for) investing activities	31,209	(65,534)	(156,504)
Equity:
Dividends paid	(61,974)	(56,992)	(50,371)
Reacquisition of shares on open market	(49,991)	(79,999)	(49,988)
Stock options exercised - net of shares reacquired	13,056	23,232	22,375
Excess tax benefit from stock-based compensation	3,603	6,097	3,290
Debt:
Net decrease in short-term debt	0	(1,003)	(2,739)
Total used for financing activities	(95,306)	(108,665)	(77,433)
Effect of exchange rates on cash and cash equivalents	8,199	(3,465)	628
Increase (decrease) in cash and cash equivalents	178,858	(27,852)	(99,773)
Cash and cash equivalents at beginning of period	245,089	272,941	372,714
Cash and cash equivalents at end of period	423,947	245,089	272,941
Detail of cash used for working capital:
Accounts receivable	(2,578)	(44,120)	142
Inventories	8,551	(38,407)	(21,441)
Other current assets	(1,656)	2,549	(2,274)
Accounts payable	(11,724)	35,129	6,425
Accrued liabilities	(5,830)	(3,315)	2,541
U.S. and foreign taxes on income	15,061	6,209	6,345
Total	1,824	(41,955)	(8,262)
Supplemental disclosure of cash flow information:
Interest paid	26,690	26,158	26,918
Income taxes paid	$ 26,270	$ 25,555	$ 15,651